Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
fms-Like Tyrosine Kinase 3 | 25 | 2021 | 496 | 5.050 |
Why?
|
Protein Kinase Inhibitors | 33 | 2020 | 5640 | 2.580 |
Why?
|
Leukemia, Myeloid, Acute | 24 | 2022 | 3606 | 2.320 |
Why?
|
Staurosporine | 15 | 2020 | 242 | 2.270 |
Why?
|
Fusion Proteins, bcr-abl | 16 | 2014 | 431 | 2.120 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 14 | 2021 | 685 | 1.810 |
Why?
|
Pyrimidines | 26 | 2019 | 3011 | 1.620 |
Why?
|
Piperazines | 19 | 2015 | 2520 | 1.480 |
Why?
|
Antineoplastic Agents | 34 | 2022 | 13629 | 1.430 |
Why?
|
Mutant Proteins | 4 | 2019 | 492 | 1.200 |
Why?
|
Drug Resistance, Neoplasm | 22 | 2019 | 5230 | 1.140 |
Why?
|
Leukemia, Myeloid | 5 | 2020 | 696 | 0.990 |
Why?
|
Small Molecule Libraries | 4 | 2021 | 734 | 0.860 |
Why?
|
Proto-Oncogene Proteins c-cbl | 2 | 2020 | 120 | 0.830 |
Why?
|
Protein-Tyrosine Kinases | 10 | 2017 | 2415 | 0.830 |
Why?
|
Drug Repositioning | 2 | 2022 | 231 | 0.790 |
Why?
|
Phenylurea Compounds | 5 | 2020 | 529 | 0.780 |
Why?
|
Antiviral Agents | 3 | 2022 | 3061 | 0.680 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 4 | 2012 | 367 | 0.670 |
Why?
|
Therapies, Investigational | 1 | 2020 | 111 | 0.660 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2020 | 454 | 0.610 |
Why?
|
Drug Screening Assays, Antitumor | 10 | 2019 | 717 | 0.590 |
Why?
|
Leukemia | 5 | 2015 | 1522 | 0.590 |
Why?
|
Cell Line, Tumor | 27 | 2022 | 16905 | 0.590 |
Why?
|
Drug Synergism | 11 | 2020 | 1755 | 0.570 |
Why?
|
Thiophenes | 2 | 2017 | 587 | 0.530 |
Why?
|
Benzothiazoles | 4 | 2020 | 246 | 0.530 |
Why?
|
Point Mutation | 4 | 2014 | 1594 | 0.530 |
Why?
|
Cell Proliferation | 23 | 2021 | 10434 | 0.520 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2020 | 2927 | 0.520 |
Why?
|
Mutation | 20 | 2021 | 29950 | 0.500 |
Why?
|
Enzyme Inhibitors | 9 | 2016 | 3726 | 0.500 |
Why?
|
Proto-Oncogene Proteins c-kit | 4 | 2019 | 729 | 0.480 |
Why?
|
Imidazoles | 2 | 2012 | 1178 | 0.470 |
Why?
|
Tumor Cells, Cultured | 18 | 2021 | 6131 | 0.460 |
Why?
|
Apoptosis | 24 | 2021 | 9497 | 0.450 |
Why?
|
Isoquinolines | 1 | 2015 | 353 | 0.450 |
Why?
|
Stromal Cells | 4 | 2013 | 1327 | 0.450 |
Why?
|
Hematologic Neoplasms | 3 | 2022 | 1899 | 0.440 |
Why?
|
Benzamides | 15 | 2010 | 1369 | 0.430 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2015 | 368 | 0.420 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3086 | 0.410 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3206 | 0.410 |
Why?
|
Up-Regulation | 4 | 2021 | 4127 | 0.410 |
Why?
|
Inhibitor of Apoptosis Proteins | 2 | 2010 | 197 | 0.410 |
Why?
|
Thiazoles | 4 | 2012 | 1509 | 0.400 |
Why?
|
Receptor, IGF Type 1 | 1 | 2014 | 380 | 0.400 |
Why?
|
Genes, ras | 1 | 2014 | 654 | 0.390 |
Why?
|
Proto-Oncogene Proteins c-akt | 5 | 2016 | 2449 | 0.380 |
Why?
|
Pyrazoles | 6 | 2021 | 1992 | 0.370 |
Why?
|
Molecular Structure | 8 | 2019 | 1895 | 0.370 |
Why?
|
Niacinamide | 1 | 2012 | 414 | 0.360 |
Why?
|
Mice | 41 | 2024 | 81216 | 0.350 |
Why?
|
Protease Inhibitors | 4 | 2020 | 755 | 0.340 |
Why?
|
Mice, Nude | 11 | 2019 | 3605 | 0.340 |
Why?
|
Transcription Factors | 5 | 2024 | 12100 | 0.330 |
Why?
|
Carbanilides | 1 | 2008 | 18 | 0.320 |
Why?
|
Benzimidazoles | 3 | 2020 | 858 | 0.310 |
Why?
|
Signal Transduction | 21 | 2020 | 23363 | 0.310 |
Why?
|
Animals | 53 | 2024 | 167940 | 0.310 |
Why?
|
Cell Cycle | 10 | 2015 | 2937 | 0.300 |
Why?
|
Phosphorylation | 17 | 2021 | 8314 | 0.300 |
Why?
|
Pyrazines | 4 | 2021 | 1200 | 0.300 |
Why?
|
src-Family Kinases | 1 | 2010 | 534 | 0.290 |
Why?
|
Structure-Activity Relationship | 9 | 2019 | 3086 | 0.280 |
Why?
|
Multiple Myeloma | 4 | 2022 | 5131 | 0.280 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2014 | 1729 | 0.270 |
Why?
|
Genes, abl | 1 | 2006 | 69 | 0.270 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2021 | 11708 | 0.260 |
Why?
|
Aniline Compounds | 3 | 2021 | 1068 | 0.260 |
Why?
|
Receptor Protein-Tyrosine Kinases | 5 | 2013 | 1614 | 0.260 |
Why?
|
Biomimetic Materials | 1 | 2007 | 173 | 0.260 |
Why?
|
Xenograft Model Antitumor Assays | 9 | 2021 | 3584 | 0.250 |
Why?
|
Dose-Response Relationship, Drug | 11 | 2019 | 10829 | 0.250 |
Why?
|
MAP Kinase Kinase Kinases | 2 | 2016 | 256 | 0.250 |
Why?
|
Piperidines | 5 | 2020 | 1650 | 0.240 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2022 | 8498 | 0.240 |
Why?
|
Histone Deacetylase Inhibitors | 4 | 2006 | 772 | 0.230 |
Why?
|
Inhibitory Concentration 50 | 4 | 2015 | 465 | 0.230 |
Why?
|
Cell Cycle Proteins | 2 | 2014 | 3448 | 0.220 |
Why?
|
Pandemics | 2 | 2020 | 8621 | 0.220 |
Why?
|
Bone Marrow Cells | 5 | 2013 | 2424 | 0.210 |
Why?
|
Humans | 76 | 2024 | 760261 | 0.210 |
Why?
|
Quinolines | 1 | 2008 | 759 | 0.200 |
Why?
|
Protein Kinase C | 2 | 2008 | 1201 | 0.200 |
Why?
|
Hematopoietic Stem Cells | 4 | 2024 | 3390 | 0.200 |
Why?
|
Mice, Inbred NOD | 2 | 2017 | 1837 | 0.200 |
Why?
|
Nuclear Proteins | 4 | 2014 | 5793 | 0.200 |
Why?
|
Oligopeptides | 1 | 2007 | 1188 | 0.190 |
Why?
|
Drug Discovery | 4 | 2014 | 1056 | 0.190 |
Why?
|
Mitochondrial Proteins | 1 | 2007 | 979 | 0.190 |
Why?
|
Pyrroles | 2 | 2019 | 1137 | 0.180 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2006 | 615 | 0.180 |
Why?
|
Cell Survival | 8 | 2019 | 5796 | 0.180 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2021 | 174 | 0.180 |
Why?
|
Hydroxamic Acids | 5 | 2006 | 482 | 0.170 |
Why?
|
Phenylethanolamine N-Methyltransferase | 3 | 1989 | 18 | 0.170 |
Why?
|
Tyrosine | 3 | 2011 | 1440 | 0.170 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2021 | 397 | 0.160 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2021 | 1628 | 0.160 |
Why?
|
Pyrimidinones | 3 | 2021 | 383 | 0.160 |
Why?
|
Xenopus Proteins | 2 | 1998 | 434 | 0.160 |
Why?
|
Myeloproliferative Disorders | 2 | 2021 | 612 | 0.160 |
Why?
|
Cell Line | 8 | 2012 | 15626 | 0.160 |
Why?
|
Models, Molecular | 10 | 2017 | 5429 | 0.150 |
Why?
|
Janus Kinase 2 | 1 | 2021 | 541 | 0.150 |
Why?
|
Triazines | 1 | 2019 | 310 | 0.140 |
Why?
|
Acetamides | 1 | 2019 | 256 | 0.140 |
Why?
|
Class III Phosphatidylinositol 3-Kinases | 1 | 2016 | 17 | 0.140 |
Why?
|
Naphthyridines | 1 | 2017 | 141 | 0.130 |
Why?
|
Leukemia, B-Cell | 1 | 2016 | 84 | 0.130 |
Why?
|
Neoplasms, Experimental | 2 | 2019 | 1229 | 0.130 |
Why?
|
Ubiquitin | 2 | 2017 | 840 | 0.130 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2005 | 1539 | 0.130 |
Why?
|
Glycogen Synthase | 1 | 2015 | 62 | 0.120 |
Why?
|
Cell Lineage | 1 | 2024 | 2525 | 0.120 |
Why?
|
Cell Division | 7 | 2005 | 4462 | 0.120 |
Why?
|
Pyridines | 3 | 2012 | 2877 | 0.120 |
Why?
|
Tyrosine 3-Monooxygenase | 3 | 1992 | 370 | 0.120 |
Why?
|
Glycogen | 1 | 2015 | 251 | 0.120 |
Why?
|
Gene Knockdown Techniques | 2 | 2021 | 1617 | 0.120 |
Why?
|
K562 Cells | 4 | 2011 | 640 | 0.120 |
Why?
|
Proto-Oncogene Proteins | 3 | 2004 | 4494 | 0.120 |
Why?
|
Burkitt Lymphoma | 1 | 2016 | 333 | 0.110 |
Why?
|
Carrier Proteins | 1 | 2007 | 4938 | 0.110 |
Why?
|
Half-Life | 2 | 2012 | 652 | 0.110 |
Why?
|
Models, Biological | 6 | 2011 | 9468 | 0.110 |
Why?
|
Immunoblotting | 2 | 2010 | 1649 | 0.110 |
Why?
|
RNA Interference | 1 | 2022 | 2846 | 0.110 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2013 | 76 | 0.110 |
Why?
|
Cell Growth Processes | 2 | 2010 | 384 | 0.110 |
Why?
|
Base Sequence | 9 | 2014 | 12447 | 0.110 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2002 | 2823 | 0.110 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2013 | 114 | 0.100 |
Why?
|
Adrenal Medulla | 2 | 1992 | 56 | 0.100 |
Why?
|
Histones | 2 | 2022 | 2583 | 0.100 |
Why?
|
Cell Adhesion | 3 | 2002 | 3096 | 0.100 |
Why?
|
Mice, Inbred BALB C | 4 | 2019 | 6226 | 0.100 |
Why?
|
GTP Phosphohydrolases | 1 | 2015 | 516 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2014 | 642 | 0.100 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2015 | 600 | 0.100 |
Why?
|
Pimozide | 1 | 2011 | 21 | 0.100 |
Why?
|
Enzyme Stability | 1 | 2011 | 220 | 0.090 |
Why?
|
Oncogenes | 1 | 1997 | 1221 | 0.090 |
Why?
|
Transforming Growth Factor beta | 1 | 1998 | 1956 | 0.090 |
Why?
|
Cell Adhesion Molecules | 1 | 1997 | 1602 | 0.090 |
Why?
|
Protein Kinases | 3 | 2008 | 1612 | 0.090 |
Why?
|
Oleanolic Acid | 1 | 2010 | 42 | 0.090 |
Why?
|
Indazoles | 1 | 2012 | 302 | 0.090 |
Why?
|
Crystallography, X-Ray | 3 | 2016 | 1979 | 0.090 |
Why?
|
Mice, SCID | 1 | 2015 | 2627 | 0.090 |
Why?
|
STAT5 Transcription Factor | 1 | 2011 | 264 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-abl | 1 | 2010 | 140 | 0.090 |
Why?
|
Cold Temperature | 2 | 1992 | 780 | 0.080 |
Why?
|
Threonine | 1 | 2010 | 272 | 0.080 |
Why?
|
Tumor Burden | 1 | 2015 | 1897 | 0.080 |
Why?
|
RNA, Messenger | 5 | 2015 | 12762 | 0.080 |
Why?
|
Gene Dosage | 1 | 2013 | 1218 | 0.080 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2004 | 3601 | 0.080 |
Why?
|
Sulfonamides | 2 | 2021 | 1973 | 0.080 |
Why?
|
Biological Products | 1 | 2017 | 914 | 0.080 |
Why?
|
RNA, Small Interfering | 2 | 2015 | 3443 | 0.080 |
Why?
|
Luminescent Measurements | 1 | 2010 | 377 | 0.080 |
Why?
|
Pyridones | 1 | 2013 | 788 | 0.070 |
Why?
|
PTEN Phosphohydrolase | 1 | 2013 | 1115 | 0.070 |
Why?
|
Adenine | 3 | 2019 | 976 | 0.070 |
Why?
|
Lymphoma, B-Cell | 1 | 2014 | 935 | 0.070 |
Why?
|
Transfection | 5 | 2002 | 5782 | 0.070 |
Why?
|
Adrenal Glands | 1 | 1989 | 556 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2024 | 11480 | 0.070 |
Why?
|
Enzyme Activation | 3 | 2008 | 3604 | 0.070 |
Why?
|
Clinical Trials as Topic | 4 | 2009 | 8058 | 0.070 |
Why?
|
Phosphotyrosine | 1 | 2006 | 456 | 0.060 |
Why?
|
Cell Communication | 1 | 2013 | 1642 | 0.060 |
Why?
|
Metabolomics | 1 | 2015 | 1626 | 0.060 |
Why?
|
Hydrolases | 1 | 2006 | 146 | 0.060 |
Why?
|
Amino Acid Substitution | 1 | 2010 | 1737 | 0.060 |
Why?
|
HEK293 Cells | 3 | 2021 | 4264 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2016 | 5248 | 0.060 |
Why?
|
DNA, Complementary | 3 | 2004 | 1993 | 0.060 |
Why?
|
Retroviridae | 2 | 2005 | 850 | 0.060 |
Why?
|
Ubiquitination | 2 | 2020 | 1010 | 0.060 |
Why?
|
Genes | 3 | 2004 | 1845 | 0.060 |
Why?
|
Protein Structure, Tertiary | 5 | 2019 | 3800 | 0.060 |
Why?
|
DNA-Binding Proteins | 3 | 1999 | 9590 | 0.060 |
Why?
|
Cloning, Molecular | 5 | 2004 | 4172 | 0.060 |
Why?
|
Mycoplasma | 1 | 2005 | 138 | 0.060 |
Why?
|
Acetylation | 2 | 2004 | 1062 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 4 | 2002 | 3735 | 0.060 |
Why?
|
Interleukin-3 | 2 | 2004 | 429 | 0.060 |
Why?
|
Flow Cytometry | 4 | 2015 | 5873 | 0.060 |
Why?
|
Molecular Sequence Data | 11 | 2004 | 17628 | 0.060 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2008 | 645 | 0.060 |
Why?
|
Binding Sites | 6 | 2019 | 6050 | 0.060 |
Why?
|
Proteomics | 1 | 2017 | 3810 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2016 | 2866 | 0.060 |
Why?
|
Aminopeptidases | 1 | 2003 | 95 | 0.050 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2004 | 2755 | 0.050 |
Why?
|
Gene Expression | 2 | 2015 | 7592 | 0.050 |
Why?
|
GATA1 Transcription Factor | 1 | 2024 | 296 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2008 | 1173 | 0.050 |
Why?
|
Female | 12 | 2021 | 391011 | 0.050 |
Why?
|
mRNA Cleavage and Polyadenylation Factors | 1 | 2003 | 105 | 0.050 |
Why?
|
Models, Chemical | 1 | 2005 | 614 | 0.050 |
Why?
|
Mitochondria | 1 | 1996 | 3598 | 0.050 |
Why?
|
Tubulin | 1 | 2006 | 692 | 0.050 |
Why?
|
Cell Line, Transformed | 2 | 2001 | 871 | 0.050 |
Why?
|
Hydroquinones | 1 | 2002 | 34 | 0.050 |
Why?
|
Molecular Targeted Therapy | 2 | 2011 | 2805 | 0.050 |
Why?
|
Leucine | 1 | 2003 | 548 | 0.050 |
Why?
|
Boronic Acids | 1 | 2006 | 914 | 0.050 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2007 | 1135 | 0.050 |
Why?
|
Amino Acid Sequence | 7 | 2016 | 13456 | 0.050 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2003 | 409 | 0.050 |
Why?
|
Smad2 Protein | 2 | 1998 | 145 | 0.050 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2008 | 2058 | 0.050 |
Why?
|
Smad Proteins | 2 | 1998 | 158 | 0.050 |
Why?
|
Trans-Activators | 3 | 2004 | 2861 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2010 | 2563 | 0.050 |
Why?
|
Adamantane | 1 | 2002 | 169 | 0.050 |
Why?
|
Smad4 Protein | 2 | 1998 | 191 | 0.050 |
Why?
|
Tandem Repeat Sequences | 1 | 2021 | 181 | 0.040 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2019 | 1346 | 0.040 |
Why?
|
Phthalazines | 1 | 2002 | 377 | 0.040 |
Why?
|
Male | 14 | 2019 | 359413 | 0.040 |
Why?
|
Xenopus | 2 | 1998 | 717 | 0.040 |
Why?
|
Membrane Proteins | 2 | 2015 | 7854 | 0.040 |
Why?
|
Lung Neoplasms | 3 | 2016 | 13249 | 0.040 |
Why?
|
Methylation | 1 | 2022 | 1080 | 0.040 |
Why?
|
Gastrula | 1 | 1998 | 82 | 0.040 |
Why?
|
Nerve Growth Factors | 2 | 1998 | 562 | 0.040 |
Why?
|
Morpholines | 2 | 2013 | 583 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2003 | 1246 | 0.040 |
Why?
|
Drug Resistance | 2 | 2021 | 1617 | 0.040 |
Why?
|
Hydrogen Bonding | 2 | 2012 | 291 | 0.040 |
Why?
|
Smad3 Protein | 1 | 1998 | 168 | 0.040 |
Why?
|
Sirolimus | 1 | 2005 | 1548 | 0.040 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1999 | 385 | 0.040 |
Why?
|
Bone Marrow Transplantation | 2 | 2003 | 2696 | 0.040 |
Why?
|
Streptomyces | 1 | 2017 | 91 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 10340 | 0.040 |
Why?
|
Genes, src | 1 | 1997 | 51 | 0.040 |
Why?
|
Schizosaccharomyces | 1 | 1999 | 237 | 0.040 |
Why?
|
Inhibins | 1 | 1997 | 209 | 0.030 |
Why?
|
Microsomes, Liver | 1 | 2016 | 173 | 0.030 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 1997 | 119 | 0.030 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 1997 | 186 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2006 | 6499 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2019 | 434 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2000 | 7593 | 0.030 |
Why?
|
Bone Marrow | 2 | 2003 | 2918 | 0.030 |
Why?
|
Administration, Oral | 1 | 2003 | 4044 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2016 | 548 | 0.030 |
Why?
|
Mitochondria, Liver | 1 | 1996 | 190 | 0.030 |
Why?
|
Catalytic Domain | 1 | 2017 | 706 | 0.030 |
Why?
|
Caspase 3 | 2 | 2010 | 730 | 0.030 |
Why?
|
Fungal Proteins | 1 | 1999 | 911 | 0.030 |
Why?
|
Acrylamides | 1 | 2016 | 260 | 0.030 |
Why?
|
Mutagenesis | 1 | 2019 | 1234 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2024 | 2063 | 0.030 |
Why?
|
Mitochondria, Heart | 1 | 1996 | 229 | 0.030 |
Why?
|
Viral Proteins | 1 | 2002 | 1802 | 0.030 |
Why?
|
Forkhead Transcription Factors | 2 | 1998 | 1613 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2020 | 18968 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2005 | 3483 | 0.030 |
Why?
|
Acute Disease | 1 | 2004 | 7268 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2000 | 6067 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4573 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2020 | 64947 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2017 | 1792 | 0.030 |
Why?
|
Blotting, Western | 2 | 2015 | 5039 | 0.030 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2013 | 132 | 0.030 |
Why?
|
Cyclin D1 | 2 | 2006 | 453 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1705 | 0.030 |
Why?
|
Drug Design | 1 | 2017 | 1062 | 0.030 |
Why?
|
Rats, Inbred Strains | 2 | 1989 | 2094 | 0.020 |
Why?
|
Rats | 5 | 1996 | 23695 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 1997 | 1388 | 0.020 |
Why?
|
Glycolysis | 1 | 2015 | 828 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 1996 | 857 | 0.020 |
Why?
|
Neoplasm Proteins | 2 | 2001 | 3613 | 0.020 |
Why?
|
Drug Approval | 1 | 2017 | 816 | 0.020 |
Why?
|
Cell Movement | 1 | 2002 | 5206 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2013 | 11341 | 0.020 |
Why?
|
Precipitin Tests | 2 | 2003 | 815 | 0.020 |
Why?
|
Aminopyridines | 1 | 2013 | 564 | 0.020 |
Why?
|
Caspases | 2 | 2003 | 878 | 0.020 |
Why?
|
Cytoskeleton | 1 | 1994 | 1167 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 1996 | 1840 | 0.020 |
Why?
|
Kinetics | 1 | 2017 | 6378 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 1994 | 1134 | 0.020 |
Why?
|
Lectins, C-Type | 1 | 1992 | 591 | 0.020 |
Why?
|
Time Factors | 3 | 2005 | 40133 | 0.020 |
Why?
|
Sequence Alignment | 2 | 2004 | 2178 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3826 | 0.020 |
Why?
|
Antigens, Surface | 1 | 1992 | 1616 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 1999 | 2702 | 0.020 |
Why?
|
Autophagy | 1 | 2016 | 1336 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2015 | 18134 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29636 | 0.020 |
Why?
|
Carcinoma | 1 | 1999 | 2334 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 2 | 1996 | 8157 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 3 | 2002 | 1977 | 0.020 |
Why?
|
Purines | 1 | 2010 | 601 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2005 | 11902 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 1992 | 1434 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 1999 | 5784 | 0.020 |
Why?
|
Tubulin Modulators | 1 | 2006 | 107 | 0.020 |
Why?
|
Gelsolin | 1 | 2006 | 189 | 0.020 |
Why?
|
Cattle | 2 | 1988 | 3847 | 0.020 |
Why?
|
Dexamethasone | 2 | 2003 | 1928 | 0.020 |
Why?
|
Body Weight | 1 | 1996 | 4613 | 0.020 |
Why?
|
Treatment Failure | 1 | 2011 | 2646 | 0.010 |
Why?
|
Neoplasms | 1 | 2013 | 22066 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2021 | 58947 | 0.010 |
Why?
|
G1 Phase | 1 | 2005 | 403 | 0.010 |
Why?
|
Chromosomes, Mammalian | 1 | 2004 | 146 | 0.010 |
Why?
|
Down-Regulation | 1 | 2011 | 2918 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 1992 | 2204 | 0.010 |
Why?
|
Interleukin-6 | 2 | 2003 | 3207 | 0.010 |
Why?
|
Alleles | 1 | 2013 | 6900 | 0.010 |
Why?
|
Tumor Stem Cell Assay | 1 | 2002 | 115 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 1 | 2002 | 119 | 0.010 |
Why?
|
src Homology Domains | 1 | 2003 | 362 | 0.010 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2002 | 60 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7345 | 0.010 |
Why?
|
Caspase 9 | 1 | 2002 | 186 | 0.010 |
Why?
|
Receptors, Growth Factor | 1 | 2002 | 326 | 0.010 |
Why?
|
Enzyme Induction | 1 | 2002 | 452 | 0.010 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2003 | 428 | 0.010 |
Why?
|
Introns | 1 | 2004 | 978 | 0.010 |
Why?
|
Cysteine Endopeptidases | 1 | 2003 | 548 | 0.010 |
Why?
|
Survival Rate | 1 | 2015 | 12806 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4739 | 0.010 |
Why?
|
Kidney | 1 | 1996 | 7072 | 0.010 |
Why?
|
Serpins | 1 | 2002 | 247 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2004 | 1900 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2003 | 666 | 0.010 |
Why?
|
DNA | 2 | 1997 | 7236 | 0.010 |
Why?
|
Serine | 1 | 2003 | 831 | 0.010 |
Why?
|
Pseudogenes | 1 | 1999 | 103 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 1999 | 6855 | 0.010 |
Why?
|
Receptors, Notch | 1 | 2004 | 742 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2002 | 558 | 0.010 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2002 | 666 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12959 | 0.010 |
Why?
|
Computer Simulation | 1 | 2012 | 6210 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2003 | 1870 | 0.010 |
Why?
|
Extracellular Matrix Proteins | 1 | 2002 | 829 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2004 | 1667 | 0.010 |
Why?
|
Exons | 1 | 2004 | 2391 | 0.010 |
Why?
|
Schizosaccharomyces pombe Proteins | 1 | 1999 | 178 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2004 | 2500 | 0.010 |
Why?
|
Indoles | 1 | 2006 | 1830 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2003 | 857 | 0.010 |
Why?
|
Genes, Fungal | 1 | 1999 | 439 | 0.010 |
Why?
|
Electrophoresis | 1 | 1997 | 234 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22041 | 0.010 |
Why?
|
Spleen | 1 | 2003 | 2298 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2003 | 1314 | 0.010 |
Why?
|
Aged | 3 | 2021 | 168995 | 0.010 |
Why?
|
Central Nervous System | 1 | 2004 | 1334 | 0.010 |
Why?
|
Activins | 1 | 1997 | 210 | 0.010 |
Why?
|
Testis | 1 | 1999 | 794 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2004 | 4625 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2005 | 6543 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 1997 | 1433 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 2001 | 1995 | 0.010 |
Why?
|
NF-kappa B | 1 | 2003 | 2486 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2002 | 2104 | 0.010 |
Why?
|
Embryo, Nonmammalian | 1 | 1997 | 899 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2013 | 5797 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2003 | 2143 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2003 | 3378 | 0.010 |
Why?
|
Models, Genetic | 1 | 2003 | 3442 | 0.010 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2001 | 1591 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 4717 | 0.010 |
Why?
|
Chick Embryo | 1 | 1994 | 981 | 0.010 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 1992 | 84 | 0.010 |
Why?
|
Protein Binding | 1 | 2004 | 9336 | 0.010 |
Why?
|
Antigens, Ly | 1 | 1992 | 293 | 0.010 |
Why?
|
DNA Probes | 1 | 1992 | 551 | 0.010 |
Why?
|
Gene Deletion | 1 | 1999 | 2668 | 0.010 |
Why?
|
Epitopes | 1 | 1997 | 2506 | 0.010 |
Why?
|
Middle Aged | 2 | 2021 | 220175 | 0.010 |
Why?
|
Recurrence | 1 | 2003 | 8487 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1992 | 778 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1992 | 1765 | 0.010 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 1999 | 1858 | 0.010 |
Why?
|
Oligonucleotides | 1 | 1992 | 588 | 0.010 |
Why?
|
DNA Damage | 1 | 1999 | 2442 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 1999 | 2874 | 0.000 |
Why?
|
Lung | 1 | 2006 | 9989 | 0.000 |
Why?
|
Plasmids | 1 | 1992 | 2277 | 0.000 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1988 | 1056 | 0.000 |
Why?
|
Proteins | 1 | 2002 | 6030 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 2013 | 21065 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 2003 | 7400 | 0.000 |
Why?
|
Species Specificity | 1 | 1988 | 2413 | 0.000 |
Why?
|
Membrane Glycoproteins | 1 | 1992 | 3731 | 0.000 |
Why?
|
Adult | 1 | 2004 | 219847 | 0.000 |
Why?
|